Tech Company Financing Transactions

Aerpio Pharmaceuticals Funding Round

Aerpio Pharmaceuticals closed a $27 million Series A venture capital round on 9/1/2012. Investors included Novartis BioVenture Fund, AgeChem Venture Fund and Athenian Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

9987 Carver Rd. 420
Cincinnati, OH 45242
USA

Phone

(513) 985-1920

Website

www.aerpio.com

Email Address

[email protected]

Overview

Aerpio Pharmaceuticals, a biopharmaceutical company,develops first-in-class treatments for ocular diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stephen Hoffman

        

Chief Financial Officer

Michael Rogers

        

Chief Medical Officer

Steve Pakola

        

Chief Scientific Officer

Kevin Peters

        

President

Joseph Gardner

        

Vice President

Brandi Soldo

        

VP - Bus. Development

Mitchell Brigell

        

VP - Finance

Gina Marek

        

Browse more venture capital transactions:

Prev: 9/1/2012: Infochimps venture capital transaction
Next: 9/1/2012: Gravitant venture capital transaction

Share this article

News on VC Transactions

We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary